HIV protease inhibitor saquinavir inhibits toll-like receptor 4 activation by targeting receptor dimerization
Article in Immunopharmacology and Immunotoxicology (August 2023)
The most recent citing publications are shown below. View all 166 publications that cite this research output on Dimensions.
An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes
Article in International Journal of Molecular Sciences (August 2023)
Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
Article in Computational and Structural Biotechnology Journal (July 2023)